A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors

Clinical trial NCT04836663 · UNKNOWN

Trial details

NCT number: NCT04836663
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Endometrial Cancer, Cervical Cancer and Ovarian Cancer

Start date: 2021-04-23
Primary completion: 2022-09-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.